146 related articles for article (PubMed ID: 14985052)
1. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone.
Yu M; Cambj-Sapunar L; Kehl F; Maier KG; Takeuchi K; Miyata N; Ishimoto T; Reddy LM; Falck JR; Gebremedhin D; Harder DR; Roman RJ
Eur J Pharmacol; 2004 Feb; 486(3):297-306. PubMed ID: 14985052
[TBL] [Abstract][Full Text] [Related]
2. Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage.
Cambj-Sapunar L; Yu M; Harder DR; Roman RJ
Stroke; 2003 May; 34(5):1269-75. PubMed ID: 12677022
[TBL] [Abstract][Full Text] [Related]
3. 20-HETE agonists and antagonists in the renal circulation.
Alonso-Galicia M; Falck JR; Reddy KM; Roman RJ
Am J Physiol; 1999 Nov; 277(5):F790-6. PubMed ID: 10564244
[TBL] [Abstract][Full Text] [Related]
4. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat.
Kehl F; Cambj-Sapunar L; Maier KG; Miyata N; Kametani S; Okamoto H; Hudetz AG; Schulte ML; Zagorac D; Harder DR; Roman RJ
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1556-65. PubMed ID: 11893593
[TBL] [Abstract][Full Text] [Related]
5. Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE.
Takeuchi K; Renic M; Bohman QC; Harder DR; Miyata N; Roman RJ
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2203-11. PubMed ID: 15964920
[TBL] [Abstract][Full Text] [Related]
6. Production of 20-HETE and its role in autoregulation of cerebral blood flow.
Gebremedhin D; Lange AR; Lowry TF; Taheri MR; Birks EK; Hudetz AG; Narayanan J; Falck JR; Okamoto H; Roman RJ; Nithipatikom K; Campbell WB; Harder DR
Circ Res; 2000 Jul; 87(1):60-5. PubMed ID: 10884373
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin, NO, and 20-HETE interactions in mediating cerebral vasoconstriction following SAH.
Takeuchi K; Miyata N; Renic M; Harder DR; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R84-9. PubMed ID: 16166205
[TBL] [Abstract][Full Text] [Related]
8. P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid.
Zhao X; Falck JR; Gopal VR; Inscho EW; Imig JD
J Pharmacol Exp Ther; 2004 Dec; 311(3):1211-7. PubMed ID: 15316085
[TBL] [Abstract][Full Text] [Related]
9. 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C.
Lange A; Gebremedhin D; Narayanan J; Harder D
J Biol Chem; 1997 Oct; 272(43):27345-52. PubMed ID: 9341185
[TBL] [Abstract][Full Text] [Related]
10. Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles.
Sun CW; Falck JR; Harder DR; Roman RJ
Hypertension; 1999 Jan; 33(1 Pt 2):414-8. PubMed ID: 9931139
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of 20-hydroxyeicosatetraenoic acid reduce renal vasoconstrictor responsiveness.
Quilley J; Qiu Y; Hirt J
J Pharmacol Exp Ther; 2003 Oct; 307(1):223-9. PubMed ID: 12954811
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
Miyata N; Seki T; Tanaka Y; Omura T; Taniguchi K; Doi M; Bandou K; Kametani S; Sato M; Okuyama S; Cambj-Sapunar L; Harder DR; Roman RJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):77-85. PubMed ID: 15831442
[TBL] [Abstract][Full Text] [Related]
13. Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm.
Roman RJ; Renic M; Dunn KM; Takeuchi K; Hacein-Bey L
Neurol Res; 2006 Oct; 28(7):738-49. PubMed ID: 17164037
[TBL] [Abstract][Full Text] [Related]
14. Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion.
Renic M; Klaus JA; Omura T; Kawashima N; Onishi M; Miyata N; Koehler RC; Harder DR; Roman RJ
J Cereb Blood Flow Metab; 2009 Mar; 29(3):629-39. PubMed ID: 19107134
[TBL] [Abstract][Full Text] [Related]
15. Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice.
Toth P; Csiszar A; Tucsek Z; Sosnowska D; Gautam T; Koller A; Schwartzman ML; Sonntag WE; Ungvari Z
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(12):H1698-708. PubMed ID: 24097425
[TBL] [Abstract][Full Text] [Related]
16. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current.
Gebremedhin D; Lange AR; Narayanan J; Aebly MR; Jacobs ER; Harder DR
J Physiol; 1998 Mar; 507 ( Pt 3)(Pt 3):771-81. PubMed ID: 9508838
[TBL] [Abstract][Full Text] [Related]
17. A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats.
Tunctan B; Korkmaz B; Buharalioglu CK; Firat SS; Anjaiah S; Falck J; Roman RJ; Malik KU
Shock; 2008 Sep; 30(3):329-35. PubMed ID: 18323740
[TBL] [Abstract][Full Text] [Related]
18. Reversal of delayed vasospasm by TS-011 in the dual hemorrhage dog model of subarachnoid hemorrhage.
Hacein-Bey L; Harder DR; Meier HT; Varelas PN; Miyata N; Lauer KK; Cusick JF; Roman RJ
AJNR Am J Neuroradiol; 2006; 27(6):1350-4. PubMed ID: 16775295
[TBL] [Abstract][Full Text] [Related]
19. The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction.
Zhao X; Inscho EW; Bondlela M; Falck JR; Imig JD
Am J Physiol Heart Circ Physiol; 2001 Nov; 281(5):H2089-96. PubMed ID: 11668070
[TBL] [Abstract][Full Text] [Related]
20. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries.
Ma YH; Gebremedhin D; Schwartzman ML; Falck JR; Clark JE; Masters BS; Harder DR; Roman RJ
Circ Res; 1993 Jan; 72(1):126-36. PubMed ID: 8417836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
